vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and ONESPAWORLD HOLDINGS Ltd (OSW). Click either name above to swap in a different company.
ONESPAWORLD HOLDINGS Ltd is the larger business by last-quarter revenue ($242.1M vs $205.4M, roughly 1.2× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 5.0%, a 3.3% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 11.5%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $14.9M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 7.1%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
COLL vs OSW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $242.1M |
| Net Profit | $17.0M | $12.1M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 6.8% |
| Net Margin | 8.3% | 5.0% |
| Revenue YoY | 12.9% | 11.5% |
| Net Profit YoY | 35.3% | -16.2% |
| EPS (diluted) | $0.48 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $242.1M | ||
| Q3 25 | $209.4M | $258.5M | ||
| Q2 25 | $188.0M | $240.7M | ||
| Q1 25 | $177.8M | $219.6M | ||
| Q4 24 | $181.9M | $217.2M | ||
| Q3 24 | $159.3M | $241.7M | ||
| Q2 24 | $145.3M | $224.9M | ||
| Q1 24 | $144.9M | $211.2M |
| Q4 25 | $17.0M | $12.1M | ||
| Q3 25 | $31.5M | $24.3M | ||
| Q2 25 | $12.0M | $19.9M | ||
| Q1 25 | $2.4M | $15.3M | ||
| Q4 24 | $12.5M | $14.4M | ||
| Q3 24 | $9.3M | $21.6M | ||
| Q2 24 | $19.6M | $15.8M | ||
| Q1 24 | $27.7M | $21.2M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | 6.8% | ||
| Q3 25 | 29.7% | 10.2% | ||
| Q2 25 | 18.7% | 9.2% | ||
| Q1 25 | 12.2% | 7.7% | ||
| Q4 24 | 20.9% | 7.9% | ||
| Q3 24 | 21.9% | 10.3% | ||
| Q2 24 | 32.7% | 8.4% | ||
| Q1 24 | 34.1% | 8.0% |
| Q4 25 | 8.3% | 5.0% | ||
| Q3 25 | 15.0% | 9.4% | ||
| Q2 25 | 6.4% | 8.3% | ||
| Q1 25 | 1.4% | 7.0% | ||
| Q4 24 | 6.9% | 6.6% | ||
| Q3 24 | 5.9% | 8.9% | ||
| Q2 24 | 13.5% | 7.0% | ||
| Q1 24 | 19.1% | 10.0% |
| Q4 25 | $0.48 | $0.12 | ||
| Q3 25 | $0.84 | $0.23 | ||
| Q2 25 | $0.34 | $0.19 | ||
| Q1 25 | $0.07 | $0.15 | ||
| Q4 24 | $0.36 | $0.13 | ||
| Q3 24 | $0.27 | $0.20 | ||
| Q2 24 | $0.52 | $0.15 | ||
| Q1 24 | $0.71 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $16.3M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $301.7M | $542.6M |
| Total Assets | $1.7B | $707.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $16.3M | ||
| Q3 25 | $285.9M | $29.6M | ||
| Q2 25 | $222.2M | $35.0M | ||
| Q1 25 | $197.8M | $22.6M | ||
| Q4 24 | $162.8M | $57.4M | ||
| Q3 24 | $120.0M | $48.8M | ||
| Q2 24 | $271.6M | $62.5M | ||
| Q1 24 | $318.0M | $65.4M |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $85.2M | ||
| Q2 25 | — | $96.2M | ||
| Q1 25 | — | $97.4M | ||
| Q4 24 | — | $98.6M | ||
| Q3 24 | — | $98.7M | ||
| Q2 24 | — | $123.8M | ||
| Q1 24 | — | $138.6M |
| Q4 25 | $301.7M | $542.6M | ||
| Q3 25 | $274.8M | $552.8M | ||
| Q2 25 | $232.2M | $548.3M | ||
| Q1 25 | $234.4M | $530.6M | ||
| Q4 24 | $228.8M | $554.5M | ||
| Q3 24 | $234.3M | $540.1M | ||
| Q2 24 | $216.6M | $532.7M | ||
| Q1 24 | $222.2M | $515.5M |
| Q4 25 | $1.7B | $707.1M | ||
| Q3 25 | $1.6B | $732.6M | ||
| Q2 25 | $1.6B | $731.8M | ||
| Q1 25 | $1.6B | $708.7M | ||
| Q4 24 | $1.7B | $746.4M | ||
| Q3 24 | $1.6B | $734.0M | ||
| Q2 24 | $1.1B | $756.8M | ||
| Q1 24 | $1.1B | $763.6M |
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $20.0M |
| Free Cash FlowOCF − Capex | $122.4M | $14.9M |
| FCF MarginFCF / Revenue | 59.6% | 6.2% |
| Capex IntensityCapex / Revenue | 0.3% | 2.1% |
| Cash ConversionOCF / Net Profit | 7.25× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $68.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $20.0M | ||
| Q3 25 | $78.4M | $33.2M | ||
| Q2 25 | $72.4M | $20.3M | ||
| Q1 25 | $55.4M | $10.1M | ||
| Q4 24 | $84.6M | $16.6M | ||
| Q3 24 | $-9.0M | $28.6M | ||
| Q2 24 | $67.4M | $18.7M | ||
| Q1 24 | $61.9M | $15.0M |
| Q4 25 | $122.4M | $14.9M | ||
| Q3 25 | $78.3M | $27.6M | ||
| Q2 25 | $72.4M | $17.6M | ||
| Q1 25 | $54.6M | $8.4M | ||
| Q4 24 | $84.1M | $13.2M | ||
| Q3 24 | $-9.2M | $27.5M | ||
| Q2 24 | $67.1M | $17.6M | ||
| Q1 24 | $61.4M | $13.7M |
| Q4 25 | 59.6% | 6.2% | ||
| Q3 25 | 37.4% | 10.7% | ||
| Q2 25 | 38.5% | 7.3% | ||
| Q1 25 | 30.7% | 3.8% | ||
| Q4 24 | 46.2% | 6.1% | ||
| Q3 24 | -5.8% | 11.4% | ||
| Q2 24 | 46.2% | 7.8% | ||
| Q1 24 | 42.3% | 6.5% |
| Q4 25 | 0.3% | 2.1% | ||
| Q3 25 | 0.1% | 2.2% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 0.3% | 1.5% | ||
| Q3 24 | 0.2% | 0.5% | ||
| Q2 24 | 0.2% | 0.5% | ||
| Q1 24 | 0.4% | 0.6% |
| Q4 25 | 7.25× | 1.65× | ||
| Q3 25 | 2.49× | 1.36× | ||
| Q2 25 | 6.05× | 1.02× | ||
| Q1 25 | 22.92× | 0.66× | ||
| Q4 24 | 6.75× | 1.15× | ||
| Q3 24 | -0.96× | 1.33× | ||
| Q2 24 | 3.44× | 1.19× | ||
| Q1 24 | 2.23× | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
